신질환 환아에서 초음파 골량측정법을 이용한 골상태 평가 = Assesment of Bone Strength Using a New Quantitative Ultrasound Device in Children with Renal Diseases

다국어 초록 (Multilingual Abstract)

Purpose : Metabolic bone diseases have been mai or problems in children with renal diseases and steroid treatment is the main precipitating factor reducing bone mineral density(BMD). This study was performed to assess the prevalence of osteoporosis and to evaluate the clinical factors associated with decreased BMD in children with renal diseases. Methods : Forty-four children with renal diseases who were diagnosed at the Pediatric no phrology division of Ajou University hospital since Oct. 1994 were included. Using a new quantitative ultrasound device, BMD and the prevalence of osteoporosis were evaluated. The clinical and serological data were analyzed in association with decreased BMD. Results : A total of 44 patients were evaluated. The age at initial diagnosis was 6.7$\pm$4.2 years. At the time of evaluation, the chronological and bone age was 9.3$\pm$4.2 years and 8.2 $\pm$ 4.6 years, respectively. The renal diseases included nephrotic syndrome 24(54.5%), Henoch Schonlein purpura nephritis 7(15.9%), IgA nephropathy 6(13.9%), reflux nephropathy(RN) 2 (4.5%), and other renal disease 5(%). The prevalence of osteoporosis was 11%. There was no difference in the clinical factors between the long-term and the short-term treated steroid groups. Conclusion : The prevalence of osteoporosis was 12% in 44 children with renal diseases No significant factor was found in association with decreased BMD and there was no relationship between osteoporosis and steroid usage duration or cumulative dose. A new quantitative ultrasound, which is relatively easy to perform, especially in children, is expected to be in common use and will enable clinicians to evaluate metabolic bone disorders with ease.

참고문헌 (Reference)

1 Adachi JD, "Vitamin D and calcium in the prevention of corticosteroid-induced osteoporosis" 23 : 995-1000, 1996

2 Picado C, "Vertebral fractures in steroid dependent asthma and involution osteoporosis" 803-6, thorax1991;46

3 Jehle MJ, "Use of corticosteroids in nephrology. Risk and prevention of osteoporosis induction. Nephrol Dial Transplant" 15 : 565-5, 2000

4 Van Rijn RR, "Tibial quantitative ultrasound versus whole-body and lumbar spine DXA in a Dutch pediatric and adolescent population" 359 : 548-52, 2000

5 Mushtag T, "The impact of corticosteroids on growth and bone health" 87 : 93-6,

6 Frost HM, "The effect of cortisone on lamellar osteoblastic acitivity" Villaneuva AR 97-101,

7 Kanis JA, "The diagnosis of osteoporosis" 1137-41,

8 "The course of biochemical parametes of bone turnover during treatment with corticosteroids" 392-6, jclinendocrinolmetab1991;72

9 Hollister JR, "Steroid induced fractures and bone loss in patients with asthma" adi (adi): 265-8,

10 Van Der Slius IM, "Referance data for bone density and body composition measured with drual energy x ray absorptionmetry in white children and young adults" 87 : 341-7, 2002

11 Hahn TJ, "Osteopenia in patients with rheumatic diseases principle of diagnosis and therapy" 165-88, seminarthiritsrheum1976;6

12 Lequin MH,, "Normal values for tibial quantitiative ultrasonometry in Caucasian children and adolescents" 67 : 101-5, 2000

13 Harry KG, "Noninvasive assessment of bone mineral and structure: state of the art." 11 : 707-30, 1996

14 Morin D, "Measurement of bone mineral content by dual photon absorptiometry in children with nephrotic syndrome treated with corticosteroid therapy over a long period" pediatrnephrol1992;6

15 Warner JT, "Measured and predicted bone mineral content in healthy boys and girls aged 6-18 years adjustment for body size and puberty" 87 : 244-9, 1998;

16 Bolotin HH,, "Inaccurancies inherent in patient-specific dual energy x ray absorptionmetry bone mineral density measurements" 16 : 417-26, 2001

17 Suzuki Y, "Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy" 151-6, metabolism1983;32

18 Rajiv K, "Glucocorticoid-induced osteoporosis. Curr Opin Neph Hypertension" 10 : 589-95, 2001

19 Hahn TJ, "Effects of short-term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man" 111-5, jclinendocrinolmetab1981;52

20 Hahn TJ, "Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass" 274-82, jclinendocrinolmetab197439

21 Celotti F,, "Dietary calcium and mineral/vitamin supplementation:a controversial problem" 27 : 1-14, 1999

22 Abrass CK, "Clinical spectrum and complications of the nephrotic syndrome" 45 : 143-53, 1997;

23 Freundlich M, "Calcium and vitamin D metabolism metabolism in children with nephritic syndrome" 383-7, jpediatr1986;108

24 Ceasre P,, "Bone mineral content in nephrotic children on long term, alternate-day prednisone therapy. Clin Pediatr" 234-6, 1995;

25 Van Rijn RR,, "Bone densitometry in children:a critical appraisal." 13 : 700-10, 2003

26 Van Rijn RR, "Bone Densitometry in children Smeinars in Musculoskeletal Radiology" 6 : 233-9, 2002

27 Harold NR, "Biochemical markers of bone turnover Curr Opin in Endo Diabetes" 10 : 387-93, 2003

28 Madan G, "Are children with idiopathic nephritic syndrome at risk for metabolic bone disease? Am J Kid Dis 2003;41" 41 : 1163-9, 2003

29 Boloton HH, "An analysis and quantitative exposition of patient-specific systematic inaccurancies inherent in planar DXA- derived in-vivo BMD measurements" 25 : 139-51, 1998